These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 7210699
21. Mutagenic activation of arylamines by subcellular fractions of Chamaelea gallina clams exposed to environmental pollutants. Rodríguez-Ortega MJ, Rodríguez-Ariza A, Amezcua O, López-Barea J. Environ Mol Mutagen; 2003; 41(1):55-63. PubMed ID: 12552592 [Abstract] [Full Text] [Related]
22. Differential effect of a microsomal deacetylase inhibition on the mutagenicity in Salmonella typhimurium of 2-acetylaminofluorene by liver homogenates of guinea pigs, mice and rats. Okuno S, Takeishi K, Seno T. Cancer Lett; 1979 Jan; 6(1):1-5. PubMed ID: 396979 [Abstract] [Full Text] [Related]
23. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene. Holme JA, Søderlund EJ. Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756 [Abstract] [Full Text] [Related]
24. Formation of mutagenic metabolites from benzo(a)pyrene and 2-aminoanthracene by the s-9 fraction from the liver of the Northern pike (Esox lucius): inducibility with 3-methylcholanthrene and correlation with benzo[a]pyrene monooxygenase activity. Balk L, Depierre JW, Sundvall A, Rannug U. Chem Biol Interact; 1982 Jul 15; 41(1):1-13. PubMed ID: 6284388 [Abstract] [Full Text] [Related]
25. Activation of promutagens by liver homogenates isolated from female mice at different ages; lack of significant differences. Guttenplan JB, Bliznakov EG. Mech Ageing Dev; 1981 May 15; 16(1):29-35. PubMed ID: 6265715 [Abstract] [Full Text] [Related]
26. Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells. Involvement of different metabolites causing DNA-repair and bacterial mutagenesis. Brouns RM, Bos RP, von Doorn R, Henderson PT. Arch Toxicol; 1980 May 15; 45(1):53-9. PubMed ID: 6994684 [Abstract] [Full Text] [Related]
27. Selective induction of microsomal 2-acetylaminofluorene N-hydroxylation by dietary 2-acetylaminofluorene in rats. Sato M, Yoshida T, Suzuki Y, Degawa M, Hashimoto Y. Carcinogenesis; 1981 May 15; 2(7):571-4. PubMed ID: 7023732 [Abstract] [Full Text] [Related]
29. Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system. Staiano N, Erickson LC, Smith CL, Marsden E, Thorgeirsson SS. Carcinogenesis; 1983 May 15; 4(2):161-7. PubMed ID: 6337737 [Abstract] [Full Text] [Related]
31. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Schrenk D, Gant TW, Michalke A, Orzechowski A, Silverman JA, Battula N, Thorgeirsson SS. Carcinogenesis; 1994 Nov 15; 15(11):2541-6. PubMed ID: 7955103 [Abstract] [Full Text] [Related]
33. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice. Lai CC, Miller EC, Miller JA, Liem A. Carcinogenesis; 1988 Jul 15; 9(7):1295-302. PubMed ID: 3383346 [Abstract] [Full Text] [Related]
34. Genetic differences in the enzymic properties of the aromatic hydrocarbon inducible N-hydroxylation of 2-acetylaminofluorene in mouse liver. Razzouk C, Batardy-Grégoire M, Roberfroid M. Carcinogenesis; 1982 Jul 15; 3(11):1325-9. PubMed ID: 7151250 [Abstract] [Full Text] [Related]
35. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish. Guobaitis RJ, Ellingham TJ, Maddock MB. Mutat Res; 1986 Feb 15; 164(1):59-70. PubMed ID: 3512989 [Abstract] [Full Text] [Related]
36. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives. Jacobs MM, Matney TS, Griffin AC. Cancer Lett; 1977 May 15; 2(6):319-22. PubMed ID: 324608 [Abstract] [Full Text] [Related]
37. Modulating effects of beta-naphthoflavone on the induction of SCEs by model compounds with emphasis on benzo[a]pyrene. Jongen WM, Sandker GW, Goertz MP, Topp RJ, van Bladeren PJ. Mutat Res; 1988 Nov 15; 202(1):155-61. PubMed ID: 3185587 [Abstract] [Full Text] [Related]
38. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment. Traynor CA, Shane BS, Hajos AK, Winston GW. Mutat Res; 1991 Mar 15; 247(1):153-66. PubMed ID: 2002800 [Abstract] [Full Text] [Related]
39. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene. Rudo K, Meyers WC, Dauterman W, Langenbach R. Cancer Res; 1987 Nov 15; 47(22):5861-7. PubMed ID: 2822235 [Abstract] [Full Text] [Related]
40. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential. McGregor D. Mutat Res; 1975 Dec 15; 30(3):305-15. PubMed ID: 1105163 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]